Deferred Revenue
Breakdown
Segments
ContributionView metric
Drug discoveryView metric
Oncology, Neurology, and Immunology ProductView metric
Software contributionView metric
Software products and servicesView metric
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Software contribution | — | — | $150M | $111M | $103.4M | $108.4M | $100.5M | $88.8M |
| Software products and services | $31.67M | $32.98M | $75.66M | $60.59M | $47.32M | $35.41M | $66.7M | $60.76M |
| Drug discovery | $9.13M | $8.8M | $36.28M | $44.87M | $47.22M | $46.88M | $46.03M | $42.36M |
| Oncology, Neurology, and Immunology Product | — | — | $5.9M | — | — | — | $3.2M | $2.5M |
| Contribution | — | — | — | — | — | — | — | $0 |
| Total | $40.8M | $41.77M | $949K | $450K | $322K | $32K | $72K | $0 |